Sorrento Therapeutics Inc (SRNE): I expect COVISTIX revenue to start soon...

Reply Private New

Replies (2) Next 10 Prev Next

Send PM Follow Ignore

Followers	57
Posts	5700
Boards Moderated	0
Alias Born	12/13/2004

dia76ca

Re: None

Thursday, 09/30/2021 7:42:42 PM

Thursday, September 30, 2021 7:42:42 PM

I expect COVISTIX revenue to start soon and increase steadily over the next 12 months. I also expect COVIDROPS revenue as early as Q1 or Q2 2022. And I expect ABIVERTINIB and SP102 revenue within the next 9 months. The annual revenue from these 4 technologies will be in the multi-Billions. And if I am even close in these expectations, we are looking at a triple digit share price!

"The refusal of the real is the number one dogma of our time" Rene Girard

Keep Last Read

Replies (2) Next 10 Prev Next

Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:

Detailed Quote

Recent SRNE News

Form 8-K - Current report • Edgar (US Regulatory) • 11/03/2023 09:31:06 PM
Form 8-K - Current report • Edgar (US Regulatory) • 10/27/2023 08:15:31 PM
Form 8-K - Current report • Edgar (US Regulatory) • 09/13/2023 01:51:06 AM
Form 8-K - Current report • Edgar (US Regulatory) • 08/28/2023 09:25:07 PM
Form NT 10-Q - Notification of inability to timely file Form 10-Q or 10-QSB • Edgar (US Regulatory) • 08/07/2023 08:15:35 PM
Form 8-K - Current report • Edgar (US Regulatory) • 08/01/2023 10:01:54 AM
Form 8-K - Current report • Edgar (US Regulatory) • 07/13/2023 10:26:26 AM